Fasenra (benralizumab) is used for the treatment of patients with asthma.

FASENRA is an interleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa) indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

Fasenra (benralizumab) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Fasenra (benralizumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the fasenra benralizumab medicine cost price in India.

The order for Fasenra (benralizumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Benralizumab (trade name Fasenra) is a monoclonal antibody which developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125). Two Phase 3 clinical trials of benralizumab, SIROCCO and CALIMA, reported meeting their primary endpoints in 2016. It was approved by the US FDA in November 2017 for the treatment of severe eosinophilic asthma.

FASENRA (benralizumab) injection, for subcutaneous use

Generic Name: benralizumab

Injection: 30 mg/mL solution in a single-dose prefilled syringe.

Fasenra (benralizumab)

FASENRA (benralizumab) injection, for subcutaneous use is available.

Get In Touch

Fasenra (benralizumab) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Fasenra (benralizumab) on prescription and Import License in Patient's Name only.

For overseas patients, Fasenra (benralizumab) can be made available in Send your enquiry to find Fasenra (benralizumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Fasenra (benralizumab).

FDA green light for Fasenra For More Details

Managing Severe Asthma: Key Considerations When Recommending Therapy For More Details